Mirabaud Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.42M Sell
28,292
-8,774
-24% -$2.61M 6.94% 3
2025
Q4
$8.96M Sell
37,066
-3,352
-8% -$911K 4.15% 7
2025
Q3
$11M Sell
40,418
-4,404
-10% -$1.2M 5.34% 6
2025
Q2
$12.3M Buy
44,822
+5,183
+13% +$1.41M 5.74% 4
2025
Q1
$10.4M Buy
39,639
+13,157
+50% +$3.25M 5.44% 4
2024
Q4
$6.13M Sell
26,482
-4,119
-13% -$947K 2.85% 16
2024
Q3
$6.68M Sell
30,601
-2,742
-8% -$567K 2.76% 14
2024
Q2
$6.56M Sell
33,343
-14,691
-31% -$3.04M 3.02% 12
2024
Q1
$10.3M Sell
48,034
-405
-0.8% -$85.1K 4.18% 7
2023
Q4
$10.2M Buy
+48,439
New +$10.3M 4.37% 4

Other funds holding CME

Mirabaud Asset Management's CME Position: Q1 2026 in Review

Mirabaud Asset Management reduced its CME Group (CME) stake by 24% in Q1 2026, selling an estimated $2.61M and leaving 28,292 shares worth $8.42M. The position accounts for 6.94% of the portfolio, ranked #3.

Mirabaud Asset Management first reported a position in CME in Q4 2023 and has held it in 10 quarters since. The position peaked at $12.3M in Q2 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Mirabaud Asset Management held 28,292 shares of CME Group worth $8.42M as of Q1 2026.
  • Mirabaud Asset Management sold 8,774 CME Group shares in Q1 2026, an estimated $2.61M.
  • CME Group made up 6.94% of Mirabaud Asset Management's portfolio in Q1 2026, its #3 holding.
  • Mirabaud Asset Management first reported a position in CME Group in Q4 2023 and has held it in 10 quarters since.
  • Mirabaud Asset Management's CME Group position peaked at $12.3M in Q2 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Mirabaud Asset Management's 13F filing for Q1 2026, filed 13 May 2026.